Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study
Yann Touchefeu, Clément Bailly, Éric Frampas, T. Eugène, Caroline Rousseau, Mickaël Bourgeois, Céline Bossard, Alain Faivre-Chauvet, A. Rauscher, Damien Masson, A.R. David, Evelyne Cerato, Thomas Carlier, Robert M. Sharkey, David M. Goldenberg, Jacques Barbet, Françoise Kraeber‐Bodéré, Caroline Bodet‐Milin
Topics & Concepts
MedicineCarcinoembryonic antigenNuclear medicinePositron emission tomographyColorectal cancerMagnetic resonance imagingRadiologyPretargetingCancerAntibodyInternal medicineMonoclonal antibodyRadioimmunotherapyImmunologyRadiopharmaceutical Chemistry and ApplicationsPeptidase Inhibition and AnalysisMonoclonal and Polyclonal Antibodies Research